United States · FDA National Drug Code directory
Naloxone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76045-112_6503f42d-3303-497a-9653-4b6d89bf7833
- Product NDC
- 76045-112
- Form
- INJECTION, SOLUTION
- Composition / generic term
- NALOXONE HYDROCHLORIDE
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240402
- Source listing expiry
- 20261231
Source-listed ingredients
- NALOXONE HYDROCHLORIDE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 24 SYRINGE in 1 CASE (76045-112-20) / 2 mL in 1 SYRINGE (76045-112-01) · 76045-112-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →